Clinical trial
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular…
NCT00047528 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00047528 |
|---|---|
| Title | Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41 |
| Official title | Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients (C-02-41). |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Open-Angle Glaucoma, Ocular Hypertension |
| Intervention type | Drug |
| Interventions | Alcon Investigational Agent |
| Start date | Jan 1, 2001 |
| Primary completion | Nov 1, 2003 |
| Completion | Nov 1, 2003 |
| First posted | Oct 18, 2002 |
| Last update posted | Aug 5, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: